Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112778272B reveals a novel Ir-catalyzed route for 2,2'-biazaaryl ligands, offering significant cost reduction and scalable manufacturing for pharma intermediates.
Patent CN108976198B details a metal-free iodine-catalyzed route for 3-(4-pyridine) indoles. Offers cost reduction in pharma intermediate manufacturing with high purity.
Discover the novel Cu-catalyzed synthesis of trifluoromethyl-substituted dihydrofuran amines. A robust method for high-purity pharmaceutical intermediates with scalable potential.
Patent CN113105402A details a metal-free iodine-catalyzed route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN115353511A details a safe, one-pot synthesis of carbonyl-bridged biheterocycles using in-situ CO generation, offering reliable pharmaceutical intermediate supply.
Patent CN112480015B details a safe one-pot synthesis of 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel CuCl-catalyzed route offers cost reduction and scalable production for high-purity pharmaceutical intermediates without anhydrous conditions.
Novel Pd-catalyzed one-pot method for trifluoromethyl chromone quinoline. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN102964271B details a novel one-step Pd-catalyzed synthesis of 2-cyano-4'-methylbiphenyl, offering significant cost reduction and scalability for sartan drug manufacturers.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Offers cost reduction in API manufacturing and scalable production capabilities.
Patent CN116253692A enables efficient, metal-free synthesis of trifluoromethyl triazines under ambient conditions, offering significant cost savings and supply chain reliability for pharmaceutical intermediates.
Patent CN107522606B enables efficient synthesis of 1,4-ketoaldehyde with mild conditions and copper catalysis, offering supply chain reliability and cost reduction for pharmaceutical intermediates.
This patent reveals a novel Pd-catalyzed route for 2-trifluoromethyl quinazolinone, offering high yields and broad substrate scope, enabling cost reduction in pharmaceutical intermediate manufacturing.
This patent introduces a novel dual-chiral ligand enabling high enantioselectivity in asymmetric catalysis, offering significant cost reduction and supply chain reliability for API intermediates manufacturing.
Patent CN116621792B enables efficient, water-based synthesis of N-butyl-benzisothiazolinone oxide with high yield, offering sustainable cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN115611739B enables high-purity benpropenoic acid intermediate synthesis with simplified steps, safer reagents, and scalable production for global pharmaceutical supply chains.
Patent CN115260080B enables efficient one-step synthesis of indole-3-carboxamide with high substrate tolerance, offering scalable production and cost reduction for pharmaceutical intermediates.